Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

Melbourne (Australia) and Indianapolis (United States) | 8 January 2026

Telix today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44^th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA (U.S.). 

Telix will host a presentation on Monday, 12 January at 9:00 am PST (12:00 pm EST / 4:00 am AEDT, 13 January), providing an overview of the Company’s pipeline assets alongside its commercial portfolio.

The event will be webcast live here and available on demand for 30 days via the Telix Investor Relations website at ir.telixpharma.com.

In addition to the live presentation and slides, Telix will publish a comprehensive overview of all therapeutic pipeline assets in a dedicated presentation accessible on the Investor Relations website. 

Financials for the fourth quarter of 2025, will be released on 20 January, 2026.